About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Review Article 
NTRK1/2/3: biology, detection and therapy
Maristella Bungaro, Edoardo Garbo
Precision Cancer Medicine  
2024;
6:
3  
Review Article 
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
Francesco Facchinetti, Laura Gandolfi, Damien Vasseur, Laura Melocchi, Seshiru Nakazawa, Marcello Tiseo, Luc Friboulet, Giulio Rossi
Precision Cancer Medicine  
2024;
6:
2  
Review Article 
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
Marco Sposito, Ilaria Mariangela Scaglione, Alessandra Dodi, Alice Avancini, Ilaria Trestini, Daniela Tregnago, Jessica Insolda, Michele Milella, Sara Pilotto, Lorenzo Belluomini
Precision Cancer Medicine  
2024;
6:
1  
Editorial Commentary 
Quality assurance in thoracic oncology: the surgeon’s perspective
Paraskevas Lyberis, Federico Femia, Enrico Ruffini
Precision Cancer Medicine  
2023;
6:
20  
Case Report 
Locally advanced HPV-positive oropharyngeal cancer cured with single agent pembrolizumab in a patient using cannabis: a case report
Azamat Abdyraimov, Nikita Karpovich, Lesia Tkachuk, Karine Darbinyan
Precision Cancer Medicine  
2023;
6:
19  
Case Report 
A challenge in emergency department: a case report of oxaliplatin-induced Kounis syndrome
Marcello Albanesi, Raffaele Didonna, Nada Chaoul, Federica Mazzone, Marco Zurlo, Fortunato Iacovelli, Francesco Monitillo, Flavio Rimmaudo, Marco Tucci, Mauro Cives, Camillo Porta, Vito Procacci
Precision Cancer Medicine  
2023;
6:
18  
Editorial 
A quality assurance program: a clear necessity in modern oncology care
Paul Van Houtte, Dirk Van Gestel
Precision Cancer Medicine  
2023;
6:
12  
Case Report 
Endoscopic endonasal removal of nasal cavity chondrosarcoma extending to the base of the skull: a case report
Nikita I. Mikhailov, Anton M. Zaitsev, Andrew G. Rerberg, Sergei A. Kisarev, Gennadei I. Khokhrikov, Artem E. Lazarev, Olga N. Kirsanova, Tatyana M. Kobyletskaya, Tatiana S. Bezbabicheva, Angelina V. Krivobokova, Peter V. Shegay, Andrey D. Kaprin
Precision Cancer Medicine  
2023;
6:
9  
Review Article 
Radiotherapy in non-surgical management of esophageal cancer in the era of immuno-oncology: a narrative review
Hongcheng Zhu, Jingyi Shen, Mohamed Emam Sobeih, Xinmin Zhao, Huijun Zhu, Kuaile Zhao
Precision Cancer Medicine  
2023;
6:
8  
Review Article 
The use of 18F-FDG PET/CT for radiotherapy treatment planning in non-small cell lung cancer: a mini-review
Eleni Gkika, Anca L. Grosu, Ursula Nestle
Precision Cancer Medicine  
2023;
6:
7  
Review Article 
Emerging drivers in non-small cell lung cancer, is there a role for immunotherapy?—a narrative review
Leonardo Brunetti, Valentina Santo, Marco Russano, Alessio Cortellini, Alessandro Galletti, Fabrizio Citarella, Giuseppina-Rita Di Fazio, Alessia Vendittelli, Giulia La Cava, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2023;
6:
6  
Original Article 
Comparison of cancer incidence and mortality between China and the United States
Zezhou Wang, Changming Zhou, Xiaoshuang Feng, Miao Mo, Jie Shen, Ying Zheng
Published online: 30 December 2021
Case Report: Precision Oncology Tumor Board 
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa
Published online: 15 June 2020
Review Article 
Non-small cell lung cancer PDL1 >50%—should we go single or combo?
Waleed Kian, Laila C. Roisman, Dina Levitas, Nadav Wallach, Adam Abo-Sharb, Aharon Y. Cohen, Alexander Yakobson, Nir Peled, Yulia Dudnik
Published online: 15 March 2020
Review Article 
NTRK and NRG1 gene fusions in advanced non-small cell lung cancer (NSCLC)
Alessandro Russo, Ana Rita Lopes, Katherine Scilla, Ranee Mehra, Vincenzo Adamo, Julio Oliveira, Stephen V. Liu, Christian Rolfo
Published online: 15 June 2020
Review Article: Precision Oncology Tumor Board 
Precision medicine: BRAF mutations in thyroid cancer
Amanda Podolski, Enrico Castellucci, Balazs Halmos
Published online: 22 November 2019
Review Article 
The structure of mTOR complexes at a glance
Huirong Yang, Xizi Chen, Mengjie Liu, Yanhui Xu
Published online: 03 August 2018
Editorial 
Diffuse large B-cell lymphoma with molecular variations more than ABC and GCB classification
Yi Miao, L. Jeffrey Medeiros, Jianyong Li, Ken H. Young
Published online: 06 July 2018
Review Article 
Alternative non-homologous end joining repair: a master regulator of genomic instability in cancer
Daniele Caracciolo, Martina Montesano, Pierosandro Tagliaferri, Pierfrancesco Tassone
Published online: 08 March 2019
Review Article 
ROS1 non-small cell lung cancer patients treatment approach
Laura Moliner, Edurne Arriola
Published online: 30 September 2021
Review Article 
ROS-1 NSCLC therapy resistance mechanism
Miguel García-Pardo, Antonio Calles
Published online: 30 June 2021
Case Report 
Giant perivascular spaces in brain: case report with a comprehensive literature review
Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta
Published online: 30 September 2022
Editorial Commentary 
PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads
Bartłomiej Tomasik, Michał Bieńkowski, Jacek Jassem
Published online: 30 June 2021
Review Article 
Circulating tumor cells: moving forward into clinical applications
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières
Published online: 15 March 2020
Editorial
AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis
Case Report: Precision Oncology Tumor Board
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa